These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 2683997)

  • 1. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease.
    Cochran AJ; Wen DR; Farzad Z; Stene MA; McBride W; Lana AM; Hoon DS; Morton DL
    Anticancer Res; 1989; 9(4):859-64. PubMed ID: 2683997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
    Cochran AJ; Pihl E; Wen DR; Hoon DS; Korn EL
    J Natl Cancer Inst; 1987 Mar; 78(3):399-405. PubMed ID: 3469453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS; Bowker RJ; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1529-33. PubMed ID: 2949828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subset alterations in nodes regional to human melanoma.
    Farzad Z; Cochran AJ; McBride WH; Gray JD; Wong V; Morton DL
    Cancer Res; 1990 Jun; 50(12):3585-8. PubMed ID: 1692763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
    Hoon DS; Korn EL; Cochran AJ
    Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
    Vuylsteke RJ; Molenkamp BG; van Leeuwen PA; Meijer S; Wijnands PG; Haanen JB; Scheper RJ; de Gruijl TD
    Clin Cancer Res; 2006 May; 12(9):2826-33. PubMed ID: 16675577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of melanoma on immune function in the regional lymph node basin.
    Negin B; Panka D; Wang W; Siddiqui M; Tawa N; Mullen J; Tahan S; Mandato L; Polivy A; Mier J; Atkins M
    Clin Cancer Res; 2008 Feb; 14(3):654-9. PubMed ID: 18245524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional lymphatic immunity in melanoma.
    Grotz TE; Mansfield AS; Jakub JW; Markovic SN
    Melanoma Res; 2012 Feb; 22(1):9-18. PubMed ID: 22082957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease.
    Mullins IM; Slingluff CL; Lee JK; Garbee CF; Shu J; Anderson SG; Mayer ME; Knaus WA; Mullins DW
    Cancer Res; 2004 Nov; 64(21):7697-701. PubMed ID: 15520172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In situ analysis of distribution of immunocompetent cells in tumor's local draining lymph nodes].
    Chen XL; He JJ; Chen K; Lai BC; Si LS; Wang YL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):748-51. PubMed ID: 17077016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
    Yamshchikov G; Thompson L; Ross WG; Galavotti H; Aquila W; Deacon D; Caldwell J; Patterson JW; Hunt DF; Slingluff CL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):909s-916s. PubMed ID: 11300491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes.
    Gerlini G; Urso C; Mariotti G; Di Gennaro P; Palli D; Brandani P; Salvadori A; Pimpinelli N; Reali UM; Borgognoni L
    Clin Immunol; 2007 Nov; 125(2):184-93. PubMed ID: 17827069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes.
    Satzger I; Völker B; Meier A; Kapp A; Gutzmer R
    Ann Surg Oncol; 2008 Jun; 15(6):1723-32. PubMed ID: 18389323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.